Next-generation sequencing has reached the “lift-off stage,” according to Yuri Milner. He’s not just saying that; he’s putting his money behind it. The famed tech investor is joining Illumina (NASDAQ:ILMN) in committing to helping early-stage genomics companies as part of a new Mission Bay accelerator. Illumina said today it’s launching a program aimed at...